The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary.

IBTR classified as TR or NP has a prognostic value for both DSS and DMFS, but depends on the classification method used. Developing and validating a generally accepted form of classification are imperative for using TR and NP in clinical practice.